Infrared fluorescence imaging of lymphatic regeneration in nonhuman primate facial vascularized composite allografts

Annals of Plastic Surgery

Volumn 68, Issue 3, 2012, Pages 314-319

  Mundinger, Gerhard S ^a   Narushima, Mitsunaga ^b   Hui Chou, Helen G ^a   Jones, Luke S ^a   Ha, Jinny S ^c   Shipley, Steven T ^c   Drachenberg, Cinthia B ^c   Dorafshar, Amir H ^a   Koshima, Isao ^b   Bartlett, Stephen T ^c   Barth, Rolf N ^c   Rodriguez, Eduardo D ^a  

^a R ADAMS COWLEY SHOCK TRAUMA CENTER   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

face transplant; fluorescent; immunosuppression; indocyanine green; light emitting diode; lymphatic; lymphedema; nonhuman primate; rejection; vascularized composite allograft

Indexed keywords

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; DIAGNOSTIC IMAGING; EVALUATION; FACE; FLUORESCENCE; GRAFT REJECTION; GRAFT SURVIVAL; LYMPH VESSEL; MACACA FASCICULARIS; METHODOLOGY; PHOTOGRAPHY; PHYSIOLOGY; REGENERATION; TRANSPLANTATION; VASCULARIZATION;

ANIMALS; DIAGNOSTIC IMAGING; FACE; FLUORESCENCE; GRAFT REJECTION; GRAFT SURVIVAL; LYMPHATIC VESSELS; MACACA FASCICULARIS; PHOTOGRAPHY; REGENERATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84857842678     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31824671e5     Document Type: Article

References (66)

1. Ravindra KV, Wu S, McKinney M, et al. Composite tissue allotransplantation: current challenges. Transplant Proc. 2009;41:3519-3528.
2. Hui-Chou HG, Nam AJ, Rodriguez ED. Clinical facial composite tissue allotransplantation: a review of the first four global experiences and future implications. Plast Reconstr Surg. 2010;125:538-546.
3. Gordon CR, Siemionow M, Papay F, et al. The world's experience with facial transplantation: what have we learned thus far? Ann Plast Surg. 2009;63: 572-578.
4. Lantieri L, Hivelin M, Audard V, et al. Feasibility, reproducibility, risks and benefits of face transplantation: a prospective study of outcomes. Am J Transplant. 2011;11:367-378.
5. Barth RN, Nam AJ, Stanwix MG, et al. Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder. Transplantation. 2009;88:1242-1250.
6. Barth RN, Bluebond-Langner R, Nam A, et al. Facial subunit composite tissue allografts in nonhuman primates: I. Technical and immunosuppressive requirements for prolonged graft survival. Plast Reconstr Surg. 2009;123: 493-501.
7. National Research Council. Guide for the care and use of laboratory animals. NIH publication No 86-23. 1985;Public Health Service, Washington, D.C.
8. Barth RN, Rodriguez ED, Mundinger GS, et al. Vascularized bone marrowbased immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. Am J Transplant. 2011;11:1407-1416.
9. Mundinger GS, Jones LS, Hui-Chou HG, et al. Costimulatory blockade does not promote survival of skin component in non-human-primate composite tissue allografts. Paper presented at: 23rd Annual International Congress of the Transplantation Society; 2010:Abstract 2606.
10. Cendales LC, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant. 2008;8:1396-1400.
11. Mundinger GS, Nam AJ, Hui-Chou HG, et al. Non-human primate model of fibula vascularized composite tissue allotransplantation demonstrates donorrecipient bony union. Plast Reconstr Surg. 2011;128:1193-1204.
12. Suami H, Chang DW, Yamada K, et al. Use of indocyanine green fluorescent lymphography for evaluating dynamic lymphatic status. Plast Reconstr Surg. 2011;127:74e-76e.
13. Mundinger GS, Hui-Chou HG, Munivenkatappa R, et al. Chronic rejection responses are distinct from acute rejection responses in non-human primate models of facial and vascularized fibula composite tissue allotransplantation. Paper presented at: American Society for Reconstructive Microsurgery Annual Meeting; January 17, 2011; Cancun, Mexico. Abstract 11461.
14. Mundinger GS. Chronic changes in non-human primate composite tissue allografts. In: 11th Banff Conference on Allograft Pathology, Composite Allografts Session. Enghien-les-Bains, Paris, France; 2011.
15. Sappey MPC. Anatomie, Physiologie, Pathologie des Vaisseaux Lymphatiques: Considérés Chez L'homme et les Vertébrés. Paris: Adrian Delahaye; 1874.
16. Yamamoto T, Narushima M, Doi K, et al. Characteristic indocyanine green lymphography findings in lower extremity lymphedema: the generation of a novel lymphedema severity staging system using dermal backflow patterns. Plast Reconstr Surg. 2011;127:1979-1986.
17. Deleted in proof.
18. Narushima M, Mihara M, Yamamoto Y, et al. The intravascular stenting method for treatment of extremity lymphedema with multiconfiguration lymphaticovenous anastomoses. Plast Reconstr Surg. 2010;125:935-943.
19. Suami H, Taylor GI, O'Neill J, et al. Refinements of the radiographic cadaver injection technique for investigating minute lymphatic vessels. Plast Reconstr Surg. 2007;120:61-67. (Pubitemid 46956031)
20. Pan WR, Suami H, Taylor GI. Lymphatic drainage of the superficial tissues of the head and neck: anatomical study and clinical implications. Plast Reconstr Surg. 2008;121:1614 -1624; discussion 1625-1616. (Pubitemid 351642712)
21. Pan WR, Le Roux CM, Briggs CA. Variations in the lymphatic drainage pattern of the head and neck: further anatomic studies and clinical implications. Plast Reconstr Surg. 2011;127:611-620.
22. Suami H, Taylor GI, Pan WR. A new radiographic cadaver injection technique for investigating the lymphatic system. Plast Reconstr Surg. 2005;115: 2007-2013. (Pubitemid 40770513)
23. Suami H, Taylor GI, Pan WR. The lymphatic territories of the upper limb: anatomical study and clinical implications. Plast Reconstr Surg. 2007;119: 1813-1822. (Pubitemid 46632068)
24. Suami H, O'Neill JK, Pan WR, et al. Perforating lymph vessels in the canine torso: direct lymph pathway from skin to the deep lymphatics. Plast Reconstr Surg. 2008;121:31-36.
25. Suami H, Pan WR, Taylor GI. Changes in the lymph structure of the upper limb after axillary dissection: radiographic and anatomical study in a human cadaver. Plast Reconstr Surg. 2007;120:982-991. (Pubitemid 47367896)
26. Smith AR, van Alphen WA, van der Pompe WB. Lymphatic drainage in patients after replantation of extremities. Plast Reconstr Surg. 1987;79:163-170.
27. Datiashvili RO, Lein AP. Restoration of lymph drainage after extremity replantation. J Reconstr Microsurg. 1990;6:325-329.
28. Clodius L. Restoration of lymph drainage after extremity replantation. J Reconstr Microsurg. 1991;7:45-47.
29. Anthony JP, Foster RD, Price DC, et al. Lymphatic regeneration following microvascular limb replantation: a qualitative and quantitative animal study. J Reconstr Microsurg. 1997;13:327-330. (Pubitemid 27328627)
30. Slavin SA, Upton J, Kaplan WD, et al. An investigation of lymphatic function following free-tissue transfer. Plast Reconstr Surg. 1997;99:730 -741; discussion 742-733. (Pubitemid 127748078)
31. Davidson JS. Interstitial fluid pressure in free vascularized skin flaps of the rat epigastrium. J Reconstr Microsurg. 2007;23:317-320. (Pubitemid 350210064)
32. Smaropoulos EC, Papazoglou LG, Patsikas MN, et al. Lymphatic regeneration following hind limb replantation: an experimental study in the dog. Eur J Pediatr Surg. 2005;15:337-342.
33. Avraham T, Daluvoy SV, Kueberuwa E, et al. Anatomical and surgical concepts in lymphatic regeneration. Breast J. 2010;16:639-643.
34. Yamamoto T, Narushima M, Doi K, et al. Characteristic indocyanine green lymphography findings in lower extremity lymphedema: the generation of a novel lymphedema severity staging system using dermal backflow patterns. Plast Reconstr Surg. In press.
35. Stanton AW, Modi S, Mellor RH, et al. Recent advances in breast cancerrelated lymphedema of the arm: lymphatic pump failure and predisposing factors. Lymphat Res Biol. 2009;7:29-45.
36. Warren AG, Slavin SA. Scar lymphedema: fact or fiction? Ann Plast Surg. 2007;59:41-45. (Pubitemid 46987976)
37. Uzarski J, Drelles MB, Gibbs SE, et al. The resolution of lymphedema by interstitial flow in the mouse tail skin. Am J Physiol Heart Circ Physiol. 2008;294:H1326-H1334. (Pubitemid 351468731)
38. Olszewski WL, Ambujam PJ, Zaleska M, et al. Where do lymph and tissue fluid accumulate in lymphedema of the lower limbs caused by obliteration of lymphatic collectors? Lymphology. 2009;42:105-111.
39. Slavin SA, Van den Abbeele AD, Losken A, et al. Return of lymphatic function after flap transfer for acute lymphedema. Ann Surg. 1999;229:421-427. (Pubitemid 30191779)
40. Tobbia D, Semple J, Baker A, et al. Lymphedema development and lymphatic function following lymph node excision in sheep. J Vasc Res. 2009;46:426-434.
41. Chen HC, O'Brien BM, Rogers IW, et al. Lymph node transfer for the treatment of obstructive lymphoedema in the canine model. Br J Plast Surg. 1990;43:578-586. (Pubitemid 20310626)
42. Lin CH, Ali R, Chen SC, et al. Vascularized groin lymph node transfer using the wrist as a recipient site for management of postmastectomy upper extremity lymphedema. Plast Reconstr Surg. 2009;123:1265-1275.
43. Mihara M, Uchida G, Hara H, et al. Lymphaticovenous anastomosis for facial lymphoedema after multiple courses of therapy for head-and-neck cancer. J Plast Reconstr Aesthet Surg. 2011.
44. Vass DG, Hughes J, Marson LP. Restorative and rejection-associated lymphangiogenesis after renal transplantation: friend or foe? Transplantation. 2009;88:1237-1239.
45. Kerjaschki D. Lymphatic neoangiogenesis in renal transplants: a driving force of chronic rejection? J Nephrol. 2006;19:403-406. (Pubitemid 44823194)
46. Kong XQ, Wang LX, Kong DG. Cardiac lymphatic interruption is a major cause for allograft failure after cardiac transplantation. Lymphat Res Biol. 2007;5:45-47.
47. Suzuki J, Isobe M, Morishita R, et al. Characteristics of chronic rejection in heart transplantation: important elements of pathogenesis and future treatments. Circ J. 2010;74:233-239.
48. Demetris AJ, Murase N, Ye Q, et al. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol. 1997;150:563-578. (Pubitemid 27073785)
49. Kerjaschki D, Huttary N, Raab I, et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med. 2006;12:230-234. (Pubitemid 43214751)
50. Kerjaschki D, Regele HM, Moosberger I, et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol. 2004;15:603-612. (Pubitemid 38294790)
51. Baddoura FK, Nasr IW, Wrobel B, et al. Lymphoid neogenesis in murine ccardiac allografts undergoing chronic rejection. Am J Transplant. 2005;5: 510-516. (Pubitemid 40313342)
52. Larsen CP, Steinman RM, Witmer-Pack M, et al. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med. 1990;172: 1483-1493. (Pubitemid 20366224)
53. Richters CD, van Gelderop E, du Pont JS, et al. Migration of dendritic cells to the draining lymph node after allogeneic or congeneic rat skin transplantation. Transplantation. 1999;67:828-832. (Pubitemid 29169127)
54. Richards DM, Dalheimer SL, Ehst BD, et al. Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease. J Immunol. 2004;172:3469-3479. (Pubitemid 38337927)
55. Mathes DW, Randolph MA, Solari MG, et al. Split tolerance to a composite tissue allograft in a swine model. Transplantation. 2003;75:25-31. (Pubitemid 36139690)
56. Muramatsu K, Kurokawa Y, Ihara K, et al. Donor cell engraftment in recipient lymphoid tissues after rat limb allograft. J Surg Res. 2005;124: 38-44. (Pubitemid 40269799)
57. Demetris AJ, Murase N, Fung JJ, et al. The immunolymphatic theory of chronic rejection. Transplant Proc. 1997;29:2615-2616. (Pubitemid 126750335)
58. Itano AA, Jenkins MK. Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol. 2003;4:733-739. (Pubitemid 36986756)
59. Cakala M, Olszewski WL. The reaction of the regional lymph nodes on the skin bacterial and allogeneic antigens. Ann Transplant. 2004;9:59-62.
60. Womer KL, Sayegh MH, Auchincloss H Jr. Involvement of the direct and indirect pathways of allorecognition in tolerance induction. Philos Trans R Soc Lond B Biol Sci. 2001;356:639-647. (Pubitemid 32575696)
61. Thaunat O, Kerjaschki D, Nicoletti A. Is defective lymphatic drainage a trigger for lymphoid neogenesis? Trends Immunol. 2006;27:441-445. (Pubitemid 44354310)
62. Kerjaschki D. How to control lymphangiogenesis: a novel role for rapamycin. Kidney Int. 2007;71:717-719. (Pubitemid 46624031)
63. Huber S, Bruns CJ, Schmid G, et al. Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis. Kidney Int. 2007;71:771-777. (Pubitemid 46624022)
64. Silverman RP, Banks ND, Detolla LJ, et al. A heterotopic primate model for facial composite tissue transplantation. Ann Plast Surg. 2008;60:209-216. (Pubitemid 351158722)
65. Morelon E, Testelin S, Petruzzo P, et al. New partial face allograft transplantation: report on first six months. Paper presented at: 2nd Biennial Meeting of the American Society for Reconstructive Transplantation, Chicago, IL; 2010: Abstract 2208.
66. Qi S, Xu D, Peng J, et al. Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey. Transplantation. 2000;69:1275-1283. (Pubitemid 30238711)